Table 2: Unadjusted and adjusted analysis Mortality with different risk factors Dilla Ethiopia, 2014.

Variables

UHR**

95% CI***

AHR****

95% CI

Gender

 

 

 

 

Male

1

1

1

1

Female

0.84

0.66-1.08

0.85

0.64-1.14

Age (per 1 year increase)

1.02

1.01-1.03

1.02

1.01-1.03

Marital Status

 

 

 

 

Married

0.95

0.64-1.41

1.02

0.68-1.53

Never Married

1

1

1

1

Divorced /Separated

0.79

0.39-1.61

0.78

0.41-1.49

Widowed

0.84

0.47-1.49

0.93

0.51-1.70

Literacy Status

 

 

 

 

Illiterate

1

1

1

1

Primary

1.18

0.73-1.64

1.07

0.72-1.60

Secondary and above

1.25

0.78-1.74

1.01

0.76-1.49

Baseline functional Status

 

 

 

 

Ambulatory

1

1

1

1

Bedridden

3.06

2.08-4.49

2.60

1.73-3.92

Working

0.50

0.37-0.67

0.74

0.53-1.02

Baseline Weight (per 1 kg increase)

0.97

0.95-0.98

0.97

0.96-0.99

WHO stage

 

 

 

 

Stage I

1

1

1

1

Stage II

2.08

0.76-5.71

1.76

0.63-4.89

Stage III

3.38

1.35-8.45

2.17

0.82-5.31

Stage IV

7.11

2.77-18.25

2.77

1.14-7.26

CD4 count at baseline

(per 1 unit increase)

0.99

0.99-1.10

0.99

0.92-1.00

Hemoglobin (per 1g/dl increase)

0.93

0.97-1.09

0.98

0.96-1.09

CPT initiation

 

 

 

 

Before

1

1

1

1

With ART

1.85

1.15-3.19

1.13

0.65-1.98

INH initiation

 

 

 

 

NO

1

1

1

1

Before ART

0.11

0.04-0.68

0.18

0.03-1.34

After ART

0.14

0.07-0.27

0.13

0.06-0.26

ART

 

 

 

 

NO

2.59

1.83-3.66

2.21

1.55-3.17

Yes

1

1

1

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

UHR: Unadjusted Hazard ratio; CI: Confidence Interval; AHR: Adjusted Hazard Ratio; WHO: World Health Organization; CPT: Cotrimoxazole Prophylaxis Treatment; IPT: Isoniazid Preventive            Therapy ART: Antiretroviral Therapy